We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

PK and Safety of Beclomethasone Dipropionate via Breath-Actuated Inhaler and Metered-Dose Inhaler

- Pharmacokinetics
- Completed

Study Title: A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Adults

Teva Identifier: BDB-AS-101

ClinicalTrials.gov Identifier: NCT02030457

Study Status: Completed

Trial Condition(s): Pharmacokinetics

Interventions: Drug: Beclomethasone dipropionate BAI | Drug: Beclomethasone dipropionate MDI

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years to 45 Years

Trial Duration: 12/01/2013 - 06/01/2014

Phase: Phase 1

Study Type

Interventional